Home
Scholarly Works
Efficacy and safety of rosuvastatin in children...
Conference

Efficacy and safety of rosuvastatin in children aged 6–17 years with familial hypercholesterolemia: Findings from the charon study

Authors

Braamskamp M; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagné C; Gaudet D; Morrison KM; Wiegman A; Turner T

Volume

235

Publisher

Elsevier

Publication Date

August 1, 2014

DOI

10.1016/j.atherosclerosis.2014.05.069

Conference proceedings

Atherosclerosis

Issue

2

ISSN

0021-9150

Contact the Experts team